Skip Ribbon Commands
Skip to main content
Back to Search Results

A phase II randomized study of the combination of Ribociclib plus goserelin acetate with Hormonal Therapy versus physician choice chemotherapy in premenopausal or perimenopausal patients with hormone receptor-positive/HER2-negative inoperable locally adva

​premenopausal, perimenopausal, HR+, LABC, MBC

Condition: Intervention: Phase:
Breast Cancer II
Status: Open (Show results)
Volunteers Required: Yes
Published Date: 20 October 2020

Term of Use/Disclaimer

All information provided within this web and mobile application is intended for general information and is provided on the understanding that no surgical and medical advice or recommendation is being rendered. Please do not disregard the professional advice of your physician.

Principal Investigator

Senior Consultant

Last updated on